The Lilly Foundation has awarded a $5.5 million grant to the Indianapolis Public Schools Foundation to support STEM education programs.

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving it more options to compete with ...

Titled Revenge on Gold Diggers and launched on the online gaming platform Steam, the China-developed game has sparked fierce debate over gender representation. The premise is simple: players guide a ...

With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.

Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics marks a strategic expansion into cardiovascular genetic medicine. The pharmaceutical giant paid a premium of about 113% over Verve’s ...

Eli Lilly said on Saturday its experimental pill orforglipron helped diabetics lose weight and lower their blood sugar, and the company aims to announce in the third quarter trial results for the ...

NEED TO KNOW Shahs of Sunset alum Lilly Ghalichi filed for divorce from husband Dara Mir after eight years of marriage This is the fourth time the former couple have filed for divorce over the ...

The Pink Retreat, an annual gathering of people who love the playfully patterned Lilly Pulitzer brand, is back in Palm Beach County June 19-22.

Chinese investors have poured their savings into gold, attracted by promises of rising prices. One company’s sudden closure is a cautionary tale.

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of experimental cardiac health drugs.

Citi forecasts a return to $2500-2700 gold prices in the second half of 2026.

(Reuters) -Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.